Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP–VPAC2 signalling pathway

Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP–VPAC2 signalling pathway

Context Modified BuShenYiQi formula (M-BYF) is derived from BuShenYiQi formula, used for the treatment of allergic asthma. The exact effect and mechanism of M-BYF on the improvement of asthma remain unclear. Objective We investigated the mechanism underlying the therapeutic effect of M-BYF on allerg...

Full description

Bibliographic Details
Main Authors: Muhua Huang, Jinfeng Wu, Jingcheng Dong
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Pharmaceutical Biology
Subjects:
chinese medicine
type 2 immune response
neuro-immune communication
airway inflammation
Online Access:http://dx.doi.org/10.1080/13880209.2021.1970198

Internet

http://dx.doi.org/10.1080/13880209.2021.1970198

Similar Items